The Human Cytomegalovirus Decathlon: Ten Critical Replication Events Provide Opportunities for Restriction
Overview
Authors
Affiliations
Human cytomegalovirus (HCMV) is a ubiquitous human pathogen that can cause severe disease in immunocompromised individuals, transplant recipients, and to the developing foetus during pregnancy. There is no protective vaccine currently available, and with only a limited number of antiviral drug options, resistant strains are constantly emerging. Successful completion of HCMV replication is an elegant feat from a molecular perspective, with both host and viral processes required at various stages. Remarkably, HCMV and other herpesviruses have protracted replication cycles, large genomes, complex virion structure and complicated nuclear and cytoplasmic replication events. In this review, we outline the 10 essential stages the virus must navigate to successfully complete replication. As each individual event along the replication continuum poses as a potential barrier for restriction, these essential checkpoints represent potential targets for antiviral development.
Lucin P, Mahmutefendic Lucin H Biomedicines. 2025; 13(2).
PMID: 40002739 PMC: 11853475. DOI: 10.3390/biomedicines13020326.
Mahmutefendic Lucin H, Stimac I, Marcelic M, Skocaj M, Lisnic B, Omerovic A Front Cell Dev Biol. 2025; 12:1517236.
PMID: 39866842 PMC: 11760598. DOI: 10.3389/fcell.2024.1517236.
SNX27:Retromer:ESCPE-1-mediated early endosomal tubulation impacts cytomegalovirus replication.
Stimac I, Marcelic M, Radic B, Viduka I, Blagojevic Zagorac G, Lukanovic Juric S Front Cell Infect Microbiol. 2024; 14:1399761.
PMID: 39359939 PMC: 11445146. DOI: 10.3389/fcimb.2024.1399761.
Bergner T, Cortez Rayas L, Freimann G, Read C, von Einem J Biomolecules. 2024; 14(9).
PMID: 39334915 PMC: 11430300. DOI: 10.3390/biom14091149.
Marschall M, Schutz M, Wild M, Socher E, Wangen C, Dhotre K Cells. 2024; 13(16.
PMID: 39195228 PMC: 11352327. DOI: 10.3390/cells13161338.